Henagliflozin, a diabetes treatment approved in China, may do more than just control blood sugar—it may actually slow biological aging.
Recent research indicates that the spatial architecture of membrane proteins is crucial for regulating T-cell signaling and activation. 3-5 In the context of CAR T cells, the nanoscale localization ...